Executives at BelCosta claimed that any issues were caused by innocent mistakes and not malicious acts.
MEDCAN24, a Thursday report, cited a state-issued letter dated April 10 that informed the lab of its suspension “effective immediately” for allegedly inflating THC levels for its clients.
California Department of Cannabis Control accused the laboratory of allowing marijuana products to be sold that failed contamination tests, and which posed a threat to customers.
A spokesman from the lab told MEDCAN24, that the company believes it is “doing everything right”, and following all the state regulations for cannabis testing.
Nate Winokur said to MEDCAN24, “We don’t think that BelCosta was anything near a health and safety concern for the public.”
In its database of licenses, DCC listed Thursday that the DCC lab permit was suspended. The license expires April 30.
In the DCC’s letter, it is not made clear whether BelCosta will be able to resume operations right away. Myron Ronay said the company may sue the government if it does not restore its license.
Ronay sent an email to MEDCAN24 saying that if they could not reach an agreement to save the company, which has been built up over the past eight years, then the courts would be the only option.
BelCosta executives have also taken to YouTube to publically refute DCC’s charges contained in the letter of suspension. They asserted that the issues raised were not rule-breaking but innocent mistakes. Winokur suggested that his firm may have “been singled out” for some reason by regulators.